JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111601200 on January 30, 2002

J. Biol. Chem., Vol. 277, Issue 15, 13184-13191, April 12, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/15/13184    most recent
M111601200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Díaz, M.
Right arrow Articles by Blanco, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Díaz, M.
Right arrow Articles by Blanco, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

DNA Polymerase lambda , a Novel DNA Repair Enzyme in Human Cells*

Miguel García-DíazDagger , Katarzyna Bebenek§, Rosario SabariegosDagger , Orlando DomínguezDagger , Josana RodríguezDagger , Tomas KirchhoffDagger , Esther García-PalomeroDagger , Angel J. PicherDagger , Raquel JuárezDagger , Jose F. RuizDagger , Thomas A. Kunkel§, and Luis BlancoDagger

From the Dagger  Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma, Madrid 28049, Spain and the § Laboratory of Molecular Genetics, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709

Received for publication, December 5, 2001, and in revised form, January 29, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA polymerase lambda (pol lambda ) is a novel family X DNA polymerase that has been suggested to play a role in meiotic recombination and DNA repair. The recent demonstration of an intrinsic 5'-deoxyribose-5-phosphate lyase activity in pol lambda  supports a function of this enzyme in base excision repair. However, the biochemical properties of the polymerization activity of this enzyme are still largely unknown. We have cloned and purified human pol lambda  to homogeneity in a soluble and active form, and we present here a biochemical description of its polymerization features. In support of a role in DNA repair, pol lambda  inserts nucleotides in a DNA template-dependent manner and is processive in small gaps containing a 5'-phosphate group. These properties, together with its nucleotide insertion fidelity parameters and lack of proofreading activity, indicate that pol lambda  is a novel beta -like DNA polymerase. However, the high affinity of pol lambda  for dNTPs (37-fold over pol beta ) is consistent with its possible involvement in DNA transactions occurring under low cellular levels of dNTPs. This suggests that, despite their similarities, pol beta  and pol lambda  have nonredundant in vivo functions.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

All known DNA polymerases are believed to share a remarkably high functional and structural similarity (1, 2). However, each of these enzymes possesses unique features that are crucial to cope with the different DNA transactions encountered while conducting DNA synthesis in vivo. Thus, in addition to the extensive DNA polymerization performed by replicative DNA polymerases, a large and growing number of enzymes have been found to be specialized in largely different and sometimes surprising types of synthesis (3-6).

Among these enzymes is mammalian pol1 beta , a member of the family X DNA polymerases. Polymerase beta  has been studied extensively and is now considered the paradigm of a repair DNA polymerase: it is ubiquitously expressed (7), and its biochemical features suggest that its in vivo role likely involves filling short gaps of DNA (8). Since its discovery, pol beta  has been suggested to play a role in DNA synthesis associated with DNA repair processes in the nucleus of mammalian cells. Indeed, it is accepted today that its polymerization features, combined with its dRP lyase activity, make pol beta  a crucial protein for base excision repair (9-11).

In addition to pol beta , all other enzymes belonging to family X (12) are small, monomeric enzymes that can be found in all realms of life, including archaea, eubacteria, eukaryotes, and viruses (13). The first family X enzyme to be identified in mammalian cells was terminal deoxynucleotidyl transferase, a template-independent enzyme that adds nucleotides at the junctions of rearranged Ig genes (14). In addition to terminal deoxynucleotidyl transferase and mammalian pol beta , a large number of family X enzymes have been now characterized in different organisms, including yeast pol IV (15, 16); pol kappa /Trf 4 (17), recently renamed as pol sigma  (18); pol µ (19); and pol lambda  (20).

Polymerase lambda  is a nuclear enzyme that has been identified in mammals as well as different high eukaryotes including other vertebrates and plants such as Arabidopsis thaliana (20-22). In addition to its 32% amino acid identity with pol beta , sequence comparison and three-dimensional structure modeling predict that pol lambda  contains all four pol beta  structural subdomains, named fingers, palm, thumb, and 8 kDa (20). However, unlike pol beta , pol lambda  has a BRCT domain at its N terminus, which likely takes part in protein-protein or protein-DNA interactions (20-22). Northern blot analysis reflects that murine and human pol lambda  mRNA is highly abundant in testis (20, 22). Moreover, predominant expression of murine pol lambda  in pachytene spermatocytes has led to the hypothesis that it plays a role in DNA repair synthesis coupled to meiotic recombination (20). Besides having an intrinsic DNA polymerase activity, and the recent demonstration of an intrinsic dRP lyase activity (23), little is known about the biochemical features of pol lambda . This is mainly because previous studies were limited by the lack of purified protein. Here, we describe the purification of human pol lambda  and its basic in vitro polymerization features and discuss novel insights into its cellular function.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials

Synthetic oligonucleotides purified by PAGE were obtained from Invitrogen. Ultrapure dNTPs, ultrapure ddNTPs, activated calf thymus DNA, [gamma -32P]ATP, [alpha -32P]dATP, and [alpha -32P]dTTP (3,000 Ci/mmol) were from Amersham Biosciences. Taq DNA polymerase was from PerkinElmer Life Sciences. T4 polynucleotide kinase was from Promega. Purified human pol beta  was a generous gift from Dr. S. H. Wilson (NIEHS).

Cloning of the Human pol lambda  cDNA

Cloning of the human POLL gene was initiated by the identification, in the public data base dbEST/GenBank, of a collection of ESTs that showed a high similarity with the mouse pol lambda  cDNA sequence, previously obtained in our laboratory (20). The several ESTs identified, with accession numbers AA742404, AA922738, AI091150, AA989195, W69567, AI123218, AI199486, AA576526, W69888, and T81701, corresponded to the 3'-untranslated region of murine pol lambda  cDNA, with the exception of EST H11886, which contained part of the coding region. Human pol lambda  cDNA was obtained from human placenta by PCR amplification. A first fragment (1419 bp long), spanning position 1107-2525 of the complete cDNA sequence (2678 nucleotides), was obtained by specific PCR using primers derived from the ESTs described above. The 3'-terminal segment, from 2526 to 2678, was deduced from the consensus of the ESTs. A second fragment (996 bp long) was obtained by semispecific PCR, using a sense primer derived from the murine sequence close to the initiation codon and an antisense primer derived from the first PCR fragment (1419 bp long), which contained the coding sequence corresponding to positions 380-1375 of human pol lambda  cDNA. The cDNA sequence was completed by 5'-rapid amplification of cDNA ends, a 504-bp long fragment that contained the untranslated 5'-region, and the initial portion of the coding region.

Therefore, the complete cDNA of human pol lambda  contains a total of 2678 bp, with a 5'-untranslated region of 371 bp (1-371), a coding sequence spanning 1728 bp (372-2099), and a 3'-untranslated region of 579 bp (2100-2678).

Overproduction and Purification of Human pol lambda  Protein

The complete coding sequence corresponding to pol lambda  was cloned in the BamHI-EcoRI sites of the bacterial expression vector pRSET-B (Invitrogen), which allows the expression of recombinant proteins as fusions with a multifunctional leader peptide containing a hexahistidyl sequence for purification on Ni2+-affinity resins (24). Expression of pol lambda  was carried out in the Escherichia coli strain BL21-CodonPlus(DE3)-RIL (Stratagene), with extra copies of the argU, ileY, and leuW tRNA genes. Expression of pol lambda  protein was induced by the addition of 1 mM IPTG to 3 liters of log phase E. coli cells grown at 28 °C in LB to an A600 of 0.5. After 20 min of induction, rifampicin was added to a final concentration of 120 µg/ml, and cells were incubated at 28 °C for 2 h. Subsequently, the cultured cells were harvested, and the pelleted cells were weighted (7.5 g) and frozen (-20 °C). Just before purification, which was carried out at 4 °C, frozen cells were thawed and ground with 5.5-fold their weight of alumina (Sigma) for 20 min, in the presence (per g of cells) of 1 volume of buffer A (50 mM Tris, pH 7.5, 10% glycerol, 0.5 mM EDTA, 1 mM DTT) supplemented with 1 M NaCl. The cell lysates were collected with 4 volumes of buffer A and 1 M NaCl. Cell debris and alumina were discarded after a 5-min centrifugation at 1,500 × g. Insoluble material was pelleted by a 20-min centrifugation at 12,000 × g. DNA was precipitated with 0.3% polyethyleneimine (10% stock solution in water, pH 7.5) and sedimented by centrifugation for 10 min at 12,000 × g. The supernatant was diluted to a final concentration of 250 mM NaCl with buffer A and precipitated with ammonium sulfate to 65% saturation to obtain a polyethyleneimine-free protein pellet. This pellet was resuspended in 100 ml of buffer A and 50 mM NaCl and loaded into a 3-ml PC column equilibrated previously in this buffer. After exhaustive washing with buffer A and 100 mM NaCl, pol lambda  was eluted with buffer A and 200 mM NaCl. The eluate containing pol lambda  was diluted with an equal volume of buffer B (50 mM Tris, pH 7.5, 10% glycerol) and loaded into a second PC column (1 ml), equilibrated previously in buffer A and 100 mM NaCl. The column was washed with buffer B supplemented with 100 mM NaCl, and the protein eluted with native binding buffer (20 mM phosphate buffer, pH 7.8, 500 mM NaCl; Invitrogen). The eluate was loaded into a Ni-NTA-agarose (Invitrogen) column equilibrated with native binding buffer. After several washing steps with native binding buffer containing increasing concentration of imidazole, pol lambda  was eluted at 400 mM imidazole. Polymerase lambda -containing fractions were collected, 5-fold diluted with buffer A, bound to a third PC column (1 ml), and eluted with buffer A containing 500 mM NaCl. This fraction contains highly purified (>99%) human pol lambda . Protein concentration was estimated by densitometry of Coomassie Blue-stained 10% SDS-polyacrylamide gels, using standards of known concentration. Under these conditions, the yield was 25 µg of purified pol lambda /g of E. coli cells. The final fraction, adjusted to 50% (v/v) glycerol and supplemented with 0.1 mg/ml BSA, was stored at -70 °C. When indicated, the pure fraction was subjected to sedimentation in a 15-30% glycerol gradient. 100 µg of protein was loaded onto a 5-ml glycerol gradient containing 20 mM Tris-HCl, pH 7.5, 0.2 M NaCl, 1 mM DTT, and 1 mM EDTA and centrifuged at 62,000 rpm (Beckman SW.50 rotor) for 26 h at 4 °C. Individual 200-µl fractions were collected from the top of the tube, examined in Coomassie Blue-stained 0.1% SDS-polyacrylamide gels, and tested for DNA polymerase activity on activated DNA.

Quantitative PCR Analysis of mRNA Expression

Quantitative PCR analysis was performed at standard conditions (LightCycler, Roche Biochemicals), using manufacturer's protocol (LightCycler Fast Start DNA Master SYBR Green I). A commercial panel of human tissue cDNA libraries (CLONTECH) was used as prenormalized cDNA templates. Each template cDNA was diluted 5-fold, and the resulting aliquot was used as a 5-fold stock for PCR. Amplification parameters were as follows: 94 °C, 5 s; 60 °C, 5 s; 72 °C, 10 s; 45 cycles (HPRT); 94 °C, 5 s; 62 °C, 5 s; 72 °C, 10 s; 45 cycles (human pol lambda  and human pol beta ). The primers, provided at 5 µM, were: HPRT952as, 5'-AACAACAATCCGCCCAAAG; HPRT554s, 5'-ATGGTCAAGGTCGCAAGCT (human HPRT); hpolbeta 700s, 5'-CCCATCCCAGCTTCACTTC; hpolbeta 1080as, 5'-CCCGGTATTTCCACTGGAT (human pol beta ); 3NTs, 5'-CCACTGCCCCTCGAAGAAT; 3NTas, 5'-TCCCAGCACCACCAGCTGC (human pol lambda ). After normalization of the various template cDNAs with the human HPRT primers, quantitative PCR of pol lambda  and pol beta  expression was carried out separately. Standard curves were made for each experiment, using series of sample dilutions. Relative expression differences were calculated by second derivate maximum analysis using the software package of LightCycler (Roche Diagnostics).

3' right-arrow 5' Exonuclease Assays

The incubation mixture, in 20 µl, contained 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 4% glycerol, 0.1 mg/ml BSA, 50 nM pol lambda , and 1.5 nM single stranded labeled P1 or P1/T6T hybrid. Reactions were incubated at 37 °C for 20 min and stopped by adding 10 mM EDTA. The 3' right-arrow 5' exonucleolysis, expected to produce a degradation ladder of the labeled P1 primer, was analyzed by 8 M urea and 20% PAGE and autoradiography.

DNA Polymerization on Activated DNA and Poly(dA)·Oligo(dT)

The standard assay (25 µl) contained 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 4% glycerol, 0.1 mg/ml BSA, 13.3 nM [alpha -32P] dTTP or dATP, and 625 ng of activated calf thymus DNA or 100 ng of poly(dA)·oligo(dT). When indicated, reaction components were added or omitted. Reactions were initiated by adding 3 nM pol lambda  or pol beta  and incubated for 10 min at 37 °C. After incubation, the reaction was stopped by adding 10 mM EDTA, and the samples were filtered through Sephadex G-50 spin columns. Polymerization activity was proportional to the amount of radioactivity present in the excluded volume, determined by counting Cerenkov radiation.

DNA Polymerization Assay on Defined DNA Molecules

Oligonucleotide P1, 5'-GATCACAGTGAGTAC, was used as the primer strand. Oligonucleotides T6A (5'-TCTATAGTACTCACTGTGATC), T6C (5'-TCTATCGTACTCACTGTGATC), T6G (5'-TCTATGGTACTCACTGTGATC), T6T (5'-TCTATTGTACTCACTGTGATC), and T18 (5'-ACTGGCCGTCGTTCTATTGTACTCACTGTGATC) were used as template strands. Oligonucleotides D1 (5'-AACGACGGCCAGT) and D1P (D1 with a 5'-phosphate), complementary to the 13 first 5'-nucleotides of T18, were used as downstream oligonucleotides to construct 5 nucleotide gaps. Oligonucleotide P1 (1 mM) was labeled at its 5'-end with [gamma -32P]ATP and T4 polynucleotide kinase. This labeled oligonucleotide was then hybridized to one (template) or two (template and downstream) oligonucleotides in the presence of 50 mM Tris-HCl, pH 7.5, and 0.3 M NaCl. The incubation mixture (20 µl) contained 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2 or 1 mM MnCl2, 1 mM DTT, 4% glycerol, 0.1 mg/ml BSA, 50 nM pol lambda  or pol beta , and 1.5 nM hybrid, indicated in each case. Reactions were started by the addition of the indicated concentration of one or each of the four dNTPs and incubated at 37 °C for the indicated times. After incubation, reactions were stopped by adding 10 mM EDTA and analyzed by 8 M urea and 20% PAGE and autoradiography.

Kinetic Analysis of DNA Polymerization

Steady-state Conditions-- DNA polymerization assays were performed as described above, using activated DNA and different dNTP concentrations. Measured enzyme velocity (fmol/min) was plotted as a function of dNTP concentration. The plotted data were fitted by a nonlinear regression curve to the Michaelis-Menten equation


V=(V<SUB><UP>max</UP></SUB>[<UP>dNTP</UP>])/(K<SUB>m</SUB>+[<UP>dNTP</UP>]) (Eq. 1)
using KaleidaGraph software (Synergy Software, www.synergy.com). Vmax and Km(app) values were obtained from the fitted curves.

Single Turnover Analysis-- Oligonucleotide P1 hybridized to oligonucleotide T6T was used as DNA substrate. Reactions (20 µl) were performed as described above using 1.5 nM substrate and 20 nM pol lambda  or pol beta . For each dNTP concentration, the amount of product formed with time was fit to a single exponential,


[<UP>product</UP>]=A(1−e<SUP>−k<SUB><UP>obs</UP></SUB>t</SUP>) (Eq. 2)
where A is the amplitude of the exponential and kobs the exponential rate constant. The obtained single exponential rate constants were plotted as a function of substrate concentration and fit to a hyperbola,
k<SUB><UP>obs</UP></SUB>=(k<SUB><UP>pol</UP></SUB>[<UP>dNTP</UP>])/(K<SUB>d</SUB>+[<UP>dNTP</UP>]) (Eq. 3)
to derive Kd and kpol values, the equilibrium dissociation constant for dNTP and intrinsic rate of insertion, respectively.

Short Gap Fidelity Assay

Gap filling reactions mixtures (20 µl) contained 50 mM Tris-HCl, pH 7.5; 10 mM MgCl2; 1 mM DTT; 0.1 mg/ml BSA; 4% glycerol; 0.5 mM each dATP, dTTP, dGTP, and dCTP; 1.6 nM gapped M13mp2 DNA; 50 nM pol lambda ; and 400 units of T4 DNA ligase. After incubation at 37 °C for 60 min, EDTA was added to 15 mM, and reaction products were resolved by electrophoresis in a neutral 0.8% agarose gel. Covalently closed, circular DNA products were electroeluted from gel slices, recovered by ethanol precipitation, introduced into E. coli MC1061 by electroporation, and plated. After scoring revertant and total plaques, the DNA of revertants was sequenced to define the sequence change responsible for the change of phenotype.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Structural Features of Human pol lambda -- The human pol lambda  cDNA was cloned on the basis of its sequence homology with murine pol lambda  (POLL gene (20); see "Experimental Procedures"). The resulting cDNA is 2678 bp in length, with a 371-bp 5'-untranslated region, a 1728-bp coding sequence, and a 579-bp 3'-untranslated region, and it exhibits 84% nucleotide sequence identity with its murine ortholog. The human POLL gene encodes a protein of 575 amino acids with an overall 83% amino acid identity to its murine ortholog. Fig. 1 shows a multiple alignment of human pol lambda  with its mouse ortholog and human pol beta . This alignment predicts several structural domains in pol lambda : an N-terminal BRCT domain (light gray area) and a connecting serine/proline-rich domain, both absent in pol beta , and a pol beta -like core containing a dRP lyase (8 kDa; gray area) and a polymerization (31 kDa; dark gray area) domain. Interestingly, the similarity between human and murine pol lambda  is maximal (92% amino acid identity) in the pol beta  core (residues 239-573 of murine pol lambda  and residues 241-575 of human pol lambda ), very high (84% amino acid identity) in the BRCT domain (residues 35-125 of murine pol lambda  and residues 36-126 of human pol lambda ), and lower (55% amino acid identity) in the serine/proline-rich domain (residues 126-238 of murine pol lambda  and residues 127-240 of human pol lambda ). Despite an overall lesser similarity, the conservation in this domain appears to be more restricted to serine, threonine, and proline residues, thus emphasizing the putative role of this region as a target for phosphorylation (20). The amino acid similarity among human pol lambda  and human pol beta  (about 33% amino acid identity) was high enough to build a computer-generated structural model of the pol beta  core of human pol lambda , whose architecture and subdomain composition (fingers, palm, thumb, and 8 kDa) are fully compatible with the three-dimensional structure of pol beta  (not shown). A closer inspection of the predicted C-terminal pol beta  core indicates that most residues characteristic of pol X family enzymes, including critical residues involved in dNTP binding, metal binding, DNA binding, and catalysis in pol beta , are also invariant or highly conserved in human pol lambda .


View larger version (90K):
[in this window]
[in a new window]
 
Fig. 1.   Multiple amino acid alignment of human and mouse orthologs of pol lambda  with human pol beta . Numbers indicate the amino acid position relative to the N terminus of each DNA polymerase. Invariant residues in the three enzymes aligned are indicated in white letters over a black background. Other amino acid identities with respect to human pol lambda  sequence are indicated in bold letters. Amino acids 36-126 (human pol lambda ) and 35-125 (murine pol lambda  (20)) are predicted to form a BRCT domain (light gray). Amino acids 241-575 (human pol lambda ) and 239-573 (murine pol lambda  (20)) form a conserved beta -core, including an 8-kDa domain (gray) and a 31-kDa polymerization domain (dark gray). The 23 amino acid residues that are invariant among all family X DNA polymerases (34) are indicated by an asterisk at the top of the alignment.

Analysis of pol lambda  mRNA Expression-- In agreement with the meiotic function proposed for pol lambda  (20), Northern blot analysis of human pol lambda  mRNA reflected high expression levels in testis (not shown and Ref. 22). However, a more sensitive reverse transcription-PCR technique detected pol lambda  mRNA in every human and murine tissue examined (not shown). We therefore performed a quantitative PCR analysis of pol lambda  expression in human tissues comparing its expression levels with those of pol beta , an enzyme thought to have a general role in DNA repair partly because of its housekeeping expression. Relative expression levels of both pol lambda  and pol beta  mRNA varied in the different tissues examined, particularly in testis and brain, where pol lambda  mRNA levels were clearly higher relative to those of pol beta  (2- and 4-fold, respectively). An opposite situation occurs in liver, where the lowest pol lambda :pol beta  ratio (1:10) was observed. Because pol lambda  expression is not only restricted to germinal cells, an additional role(s) of this enzyme in somatic cells must be considered. The observation that the relative expression of pol lambda  and pol beta  varies in some tissues suggests that the cellular functions of these two enzymes may be nonredundant.

pol lambda  Has an Intrinsic DNA Polymerase Activity-- Human pol lambda  was expressed in E. coli cells as a fusion protein containing a histidine tag at its N terminus (see "Experimental Procedures"). As shown in Fig. 2, upon IPTG induction, a new polypeptide was observed migrating at the expected position for pol lambda  (~68 kDa) and making up to 1% of the total protein extract. About 25% of the overproduced pol lambda  remained soluble and was precipitated with 65% ammonium sulfate. Polymerase lambda  was further purified using PC and Ni-NTA chromatography. The protein eluted from the Ni-NTA column as a homogeneous species as judged by SDS-PAGE and was devoid of nuclease contaminants, as tested in nuclease assays.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2.   Purification of human pol lambda . A, overexpression and purification of human pol lambda  in E. coli. Coomassie Blue staining after SDS-PAGE separation of control noninduced (NI) and IPTG-induced (I) total extracts obtained from E. coli cells transformed with the recombinant plasmid pRSET-hpollambda and further purification steps of the IPTG-induced extract (described in detail under "Experimental Procedures") are shown. The electrophoretic mobility of the overproduced pol lambda , present in the IPTG-induced total extract, was compatible with its deduced molecular mass (68 kDa/604 amino acids). After cell lysis, an important fraction of pol lambda  remained soluble (S). After polyethyleneimine precipitation of the DNA, pol lambda  was precipitated with ammonium sulfate at 65% saturation (AS), and further purified by PC and Ni-NTA (Ni) chromatography, as described under "Experimental Procedures." The electrophoretic migration of a collection of molecular mass markers (MW) is shown on the left. B, cosedimentation of a DNA polymerase activity with the human pol lambda  68-kDa polypeptide. Purified human pol lambda  was subjected to a glycerol gradient sedimentation (see "Experimental Procedures"). The inset shows the analysis of fractions 4-26 in a Coomassie Blue-stained SDS-polyacrylamide gel. DNA polymerase activity of each fraction was assayed on activated DNA and is expressed as dAMP incorporation (in pmol). Quantitation of the human pol lambda  protein band was carried out by densitometry of the stained gel and is expressed as optical density (a.u., arbitrary units).

To analyze DNA polymerization activity in the purified pol lambda  fraction, we carried out different in vitro assays using either activated DNA or defined homopolymeric molecules as a substrate. As summarized in Table I, the purified pol lambda  fraction was able to catalyze dNMP incorporation in the presence of either Mg2+ or Mn2+ divalent metal ions.

                              
View this table:
[in this window]
[in a new window]
 
Table I
DNA polymerization on activated DNA and poly(dA) · oligo(dT)
DNA polymerization activity was assayed in the standard conditions described under "Experimental Procedures." Individual components were added or omitted as indicated. The ratio of ddTTP to dTTP is indicated in parentheses. 100% activity values correspond to 30 (activated DNA) and 8.5 poly(dA · dT) fmol min-1 pmol of enzyme-1 for pol lambda  and to 3 (activated DNA) and 7 poly(dA · dT) fmol min-1 pmol of enzyme-1 for pol beta .

As a control of specificity, we carried out a parallel purification from control E. coli cells (transformed with the pRSET plasmid). In this case, no polymerization activity was detectable in the final fractions (not shown). To ascertain further that the DNA polymerase activity present in the final purification fraction was intrinsic to pol lambda , we demonstrated the cosedimentation in a glycerol gradient of the DNA polymerase activity with the 68 kDa pol lambda  protein peak, identified by Coomassie Blue staining after SDS-PAGE analysis of each gradient fraction (Fig. 2B).

In our standard assay, pol lambda  specific activity (30 fmol·min-1·pmol of enzyme-1) was 10 times higher compared with that of pol beta  (3 fmol·min-1·pmol of enzyme-1) (Table I). Interestingly, replacing magnesium ions with manganese when using poly(dA)·oligo(dT) as a substrate stimulated pol lambda  and pol beta  polymerization up to 20-fold and 30-fold, respectively. This substrate-specific effect could be explained if manganese ions facilitate the slippage capacity of both enzymes. As happens with pol beta  and other pol beta -like enzymes (15), ddNTPs inhibited polymerization by pol lambda . The inhibition observed for pol lambda  is in agreement with the weak discrimination for the 3'-OH group of the incoming nucleotide displayed by family X DNA polymerases.

pol lambda  Lacks 3' right-arrow 5' Exonuclease-- The 3' right-arrow 5' exonuclease active site of all proofreading eukaryotic and prokaryotic DNA polymerases is made up of three conserved amino acid motifs, named Exo I, Exo II, and Exo III (25). Similar motifs could not be identified in pol lambda  sequence, suggesting that, as other family X enzymes, pol lambda  has no proofreading activity. This prediction was confirmed by exonuclease assays (see "Experimental Procedures"), where purified pol lambda  failed to display any nucleolytic activity both on single stranded and template-primer substrates: a 30-fold excess of enzyme over substrate did not produce a detectable degradation (less than 0.1%) after 30 min at 37 °C (not shown).

pol lambda  Is Template-dependent and Distributive on a Template-Primer-- Although pol beta  is the closest homolog of pol lambda , the latter enzyme also shares significant sequence similarity with both terminal deoxynucleotidyl transferase and pol µ, two enzymes reported to display a template-independent DNA polymerization capacity. To assay whether pol lambda  is template-dependent or not, DNA molecules of defined sequence were used as substrates to assay DNA polymerization. Whereas pol lambda  was able to perform synthesis on a template-primer, it was unable to use single stranded DNA or blunt double stranded DNA (not shown), thus suggesting that pol lambda  is strictly a template-dependent enzyme.

Processivity is a common feature of DNA polymerases involved in extensive DNA synthesis (i.e. replicative polymerases), as a direct consequence of tight DNA binding and efficient nucleotide insertion. Conversely, DNA repair enzymes frequently display weaker DNA interactions and incorporate nucleotides more slowly and consequently synthesize DNA in a distributive mode. We used a template-primer and different enzyme:DNA ratios to study the processivity of human pol lambda . On this template, pol lambda  was absolutely distributive both in the presence of Mg2+ and Mn2+ activating ions, because the length of the synthesized products was strongly dependent on the enzyme:DNA ratio (not shown). Although it can not be discarded that accessory proteins could modulate processivity, these results suggest that pol lambda  is not well suited to carry out long patch DNA synthesis in vivo.

Processive Gap Filling by Human pol lambda -- Although being a distributive polymerase on a template-primer substrate, pol beta  is known to conduct processive DNA synthesis in small (<6) DNA gaps, believed to be its physiological substrate. Structural evidence (26) suggests that this is the consequence of the additional contacts that are established in a gapped substrate between the N-terminal 8-kDa domain of the enzyme and the DNA downstream to the gap. Among them, the capacity of the 8-kDa domain to bind a terminal 5'-phosphate group is particularly important for both processivity and binding of pol beta  during gap filling synthesis (8). We therefore compared the processivity of pols lambda  and beta  using a template-primer and a 5-nucleotide gap with or without a phosphate group at its 5'-side (Fig. 3A). As can be seen in Fig. 3B, the processivity of both enzymes was increased in the presence of a phosphate group at the 5'- side of the gap (right panels). For pol lambda , this increase was strictly dependent on the presence of a phosphate group, whereas pol beta  showed some increase in processivity (visible at longer times) even in its absence (middle panels). However, this phosphate-independent increase in processivity was only seen when the gap had been partially filled (by insertion of 3 nucleotides), suggesting the establishment of specific contacts between pol beta  and the DNA requiring a defined gap size (1-2 nucleotides). Whereas pol beta  displayed a significant strand displacement capacity and efficiently inserted one additional nucleotide after filling the gap, pol lambda  limited its synthesis to the 5 nucleotides of the gap. This imprecise gap filling by pol beta , which has been already described (8), can be overcome in vitro by association with XRCC1 protein (27). Because pol lambda  appears to be intrinsically able to restrict its synthesis to the length of the gap, it would be a suitable candidate to participate in a XRCC1-independent gap filling synthesis (28).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   Gap filling by pol lambda . A, the different molecules used in the analysis were: T/P, template-primer; Gap-5/OH, 5-nucleotide gap; Gap-5/P, 5-nucleotide gap with a 5'-phosphate. Reactions were performed as described under "Experimental Procedures" in the presence of 10 mM MgCl2 (B) or 1 mM MnCl2 (C), using the substrates indicated and 50 nM pol beta  or pol lambda  (as indicated). After incubation for 2, 5, 15, and 30 min at 37 °C, samples were analyzed by 8 M urea and 20% PAGE and autoradiography.

Strand Displacement Coupled with Gap Filling Synthesis Is Enhanced by Mn2+ Ions-- The use of Mn2+ ions as metal activators is known to affect both catalytic efficiency and fidelity of several DNA polymerases in vitro (29), including family X DNA polymerases such as pol µ (19) or pol beta  (30). Surprisingly, as shown in Fig. 3C, manganese greatly stimulated strand displacement synthesis on gapped DNA, catalyzed both by pol beta  and pol lambda . For both enzymes, the extension products obtained on the gapped substrate were comparable with those obtained in the control (no gap) template-primer molecule, and only a slight increase in the proportion of +5 and +6 products revealed that the reaction was occurring in a gapped molecule. Interestingly, this stimulation of strand displacement-coupled DNA polymerization was observed in both the presence or absence of a phosphate group at the 5'-side of the gap, although the presence of this phosphate group slightly constrained the strand displacement capacity of both enzymes.

pol lambda  Has a High Affinity for dNTPs-- An early observation was that the rate of nucleotide incorporation by pol lambda  on activated DNA was not augmented by using dNTP concentrations over 1 µM. Contrarily, a reduction in nucleotide incorporation was observed when higher amounts (100 µM) of dNTPs were used (data not shown). These data suggested that pol lambda  was saturated at a low nucleotide concentration. Therefore, a steady-state kinetic analysis of dNMP incorporation on activated DNA was performed in parallel for both pol beta  and pol lambda . The data obtained were fit to the Michaelis-Menten equation (Equation 1) and used to determine apparent Km values. Interestingly, as shown in Table II, pol lambda  displayed an Km(app) 15-fold lower than that of pol beta  (0.50 ± 0.07 and 7.60 ± 0.70 µM, respectively). This difference was investigated further using defined DNA molecules and single turnover conditions, where the enzyme concentration is higher than the concentration of DNA. Under these conditions, DNA binding differences between the two enzymes are minimized, and the kinetic constants reflect the equilibrium binding constant (Kd) and the intrinsic rate of insertion (kpol). For each dNTP concentration, the amount of product formed with time was fit to a single exponential (Equation 2) to derive the observed polymerization rate (kobs). The exponential rate constants (kobs) were then plotted as a function of substrate concentration and fit to a hyperbola (Equation 3) to obtain Kd and kpol. Single turnover analysis of dAMP incorporation clearly revealed that pol lambda  has a higher affinity for dAMP than pol beta . As shown in Table II, a 37-fold difference in the Kd was observed (0.145 ± 0.010 µM for pol lambda  and 5.384 ± 0.500 µM for pol beta ).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Kinetic constants of dAMP and ddAMP insertion
Kinetic assays were performed as described under "Experimental Procedures."

To analyze 3'-OH discrimination by pol lambda  further, we used a defined template-primer DNA molecule to compare dAMP and ddAMP incorporation. Polymerase lambda  was able to insert ddAMP efficiently. The same behavior was observed for pol beta , in agreement with previous reports (15, 31). Single turnover parameters (Table II) reflected that dAMP and ddAMP are inserted by both enzymes with a similar efficiency, suggesting that these proteins do not show a strong selection for the 3'-OH group of the nucleotide.

Fidelity of pol lambda -- We have shown previously that pol lambda  is a DNA-dependent DNA polymerase with no proofreading activity. As a first analysis of the capacity of pol lambda  to catalyze faithful DNA synthesis, each of the four dNTPs was assayed individually as a substrate to be incorporated opposite the four possible templating bases, in the presence of Mg2+ or Mn2+ ions. Fig. 4 shows that in all cases, pol lambda  preferentially inserted the correct dNTP. Thus, pol lambda  performs DNA synthesis following the Watson-Crick base pairing rules. For a more quantitative analysis, we then assayed the fidelity of pol lambda  synthesis while filling a 5-nucleotide gap in a M13mp2 DNA. This DNA substrate produces a colorless M13 plaque phenotype because of a TGA stop codon in the lacZ alpha  complementation gene sequence within the gap. As described previously (32) base substitution errors that revert the nonsense codon are scored as blue plaque revertants among total copied and ligated products. Synthesis by pol lambda  to fill in the gap generated products with a lacZ reversion frequency of 9 × 10-4, which is similar to the reversion frequency observed with pol beta . Thus, although pol lambda  base substitution fidelity is lower than that of replicative polymerases, it is relatively high when compared with that of the polymerases in the recently identified pol Y family (33). DNA sequence analysis of pol lambda -generated revertants revealed significant differences in the base substitution specificity of the two enzymes. Polymerase lambda  predominantly generates transition errors. Note that of the 55 pol lambda -produced base substitutions (Table III) only 3 were transversion errors. In contrast pol beta -generated base substitutions are more divided evenly between transitions and transversions.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Human pol lambda  preferentially incorporates complementary nucleotides. Four different template-primer structures were used, differing in the first templating base. Reactions were carried out as described under "Experimental Procedures" using 50 nM pol lambda  and 10 mM MgCl2 or 1 mM MnCl2 as a source of activating metal ions. Extension of the labeled (*) primer strand in the presence of either the correct (0.1 µM) or the incorrect (100 µM) dNTP was analyzed by 8 M urea and 20% PAGE and autoradiography.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Base substitution specificity of pol lambda  in short gap reversion assay
The error rates (E.R.) were calculated by dividing the total number of errors in a class by the total number of mutants sequenced (80), then multiplying by the mutant frequency, and then dividing by the target size. This number was then divided by 0.6, the probability of expressing an error in E. coli.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Polymerase lambda  is a recently discovered enzyme belonging to the family X of DNA polymerases (20-22). Amino acid sequence comparison among all members of this family reveals a common domain organization, which could imply a similar catalytic mechanism (34). However, despite these general similarities, family X includes heterodox polymerases such as terminal deoxynucleotidyl transferase, able to conduct template-independent synthesis, and pol µ, also endowed with some degree of template independence and extremely unfaithful (19). Although pol lambda  is the closest relative of pol beta  (33% amino acid identity), no evidence had been published to date regarding pol lambda  polymerization properties.

Unlike its murine ortholog (20), human pol lambda  could be expressed in E. coli in a soluble and active form and purified to homogeneity. Biochemical analysis of human pol lambda  showed basic features very similar to pol beta : 1) strict template dependence when using Mg2+ as metal activator; 2) lack of an intrinsic 3' right-arrow 5' exonuclease; 3) distributive on a template-primer but processive in short gaps having a phosphate group at its 5'-side; 4) low discrimination against ddNTPs; 5) preferential insertion of complementary dNMPs and similar base substitution fidelity. Moreover, as has been shown recently, pol lambda  has an intrinsic dRP lyase activity (23), an activity that is crucial for the base excision repair pathway. All of these similarities suggest that pol lambda  is a beta -like enzyme that could play a role in DNA repair in vivo.

The use of Mn2+ ions to activate pol beta  results in an increased reactivity at the catalytic site, lowering the fidelity of synthesis and even allowing template-independent reactions (30). Here we describe an additional effect of Mn2+ ions, increasing the strand displacement capacity of both pol beta  and pol lambda . This effect could be the result of Mn2+ binding to the helix-hairpin-helix motif of the 8-kDa domain of both polymerases (35), potentially distorting DNA binding and facilitating strand displacement.

Despite all their similarities, pol lambda 's lack of an apurinic/apyrimidinic lyase activity (23) or its different base substitution specificity compared with pol beta  reveal that pol lambda  and pol beta  are biochemically distinguishable. Moreover, an important difference between these two enzymes is related to the efficiency of dNTP binding and selection. Steady-state kinetic analysis reflected that the Km(app) (dNTP) of pol lambda  is an order of magnitude lower compared with that of pol beta , and consistent with single turnover experiments pol lambda  has a 37-fold higher affinity for incoming nucleotides than pol beta .

Most residues involved in dRP lyase catalysis and 5'-phosphate binding are conserved between pol beta  and pol lambda  (23). Moreover, pol lambda  conserves most pol beta  key residues related to polymerization catalysis including the three invariant aspartates that coordinate the divalent metal ions (Asp427, Asp429, and Asp490), pivotal residues that ensure fidelity of catalysis by pol beta  such as Arg283 and Phe272 (Arg517 and Phe506 in pol lambda , respectively), and other invariant residues in family X polymerases (34). However, in agreement with their biochemical differences, a strong dissimilarity can be observed at the dNTP binding pocket of both enzymes. As illustrated in Fig. 5, pol lambda  conserves most pol beta  residues that surround the incoming dNTP in the closed conformation of the ternary complex (26) but differs in some 8-kDa residues presumed to increase dNTP binding in a single nucleotide gap (i.e. pol beta  residues Arg40 and Lys27 (36)). More interestingly, pol beta  Asp276, known to make Van der Waals interactions with the base of the incoming nucleotide (11), is replaced by Ala510 in pol lambda . Besides forming the only electrostatic interaction between alpha -helix N and the 8-kDa domain of pol beta  (through hydrogen bonding with Arg40 (36)), Asp276 is believed to restrict dNTP binding. Indeed, replacing Asp276 with an uncharged residue (i.e. valine or glycine) results in an apparent increase in the nucleotide binding affinity (37). Moreover, a D276V mutant of pol beta  has a 4-9-fold increased nucleotide binding affinity compared with that of the wild-type enzyme (36). Accordingly, pol lambda , having an uncharged residue at this position (Ala510), has a 37-fold higher nucleotide binding affinity than pol beta , thus behaving similarly to the D276V mutant of pol beta .


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Structural basis for nucleotide binding by human pol lambda . The nucleotide binding pocket of human pol beta  (A) is compared with the putative (modeled) nucleotide binding pocket of human pol lambda  (B). The incoming ddCTP (red) is shown, hydrogen bonded to its templating base (light yellow). Relevant residues are shown (ball and stick), and their position relative to the N terminus of the protein is indicated. One of the most striking differences between the pol beta  and pol lambda  dNTP binding site is the nonconservation of pol beta  residue Asp276 (green), which plays a direct role in dNTP binding and selectivity (for details, see "Discussion"). A model structure of the whole beta -core of human pol lambda , with the exception of alpha -helix A, was generated with the program Swiss Model (www.expasy.ch/swissmod/swiss-model.html). The figure was made with Swiss PDB Viewer ((42) www.expasy.ch/spdbv/) and rendered with POV Ray (www.povray.org).

As shown here, it can be predicted that at a low dNTP concentration, pol lambda  would be a much more active enzyme than pol beta . This biochemical difference suggests that both enzymes, instead of having a redundant function, could play a specific role related to the cellular concentration of nucleotide precursors for DNA synthesis. Thus, DNA repair could take advantage of a dual functional solution similar to that described for glucose phosphorylation, which involves both a low Km hexokinase and a high Km glucokinase (hexokinase IV (38)). Interestingly, pol lambda  mRNA expression is apparently cell cycle-dependent, being higher in quiescent and S to M phase cycling cells (22). Thus, pol lambda  could be specialized in DNA repair taking place during specific stages of the cell cycle, required in nonproliferative cell types or during differentiation processes. Such a specialized DNA repair function in pol lambda  could be perhaps related to its N-terminal BRCT domain. This domain, absent in pol beta  but present in a large number of nuclear proteins, has been suggested to take part in different protein-protein and protein-DNA interactions (39-41). Therefore, an important difference with pol beta  could be the potential to establish (via its BRCT domain) distinct interactions that could regulate pol lambda  cellular function. Further work should be carried out to ascertain the specific pathway(s) recruiting this enzyme and its contribution to the maintenance of genetic stability.

    ACKNOWLEDGEMENTS

We thank Drs. Samuel Wilson and Rajendra Prasad for providing purified human pol beta  protein. We are also grateful to Drs. William Beard and Margarita Salas for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by Ministerio de Ciencia y Tecnología Grant BMC2000-1138, Comunidad Autónoma de Madrid Grant 08.5/0063/2000 (to L. B.) and by an institutional grant from Fundación Ramón Areces.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ131890.

To whom correspondence should be addressed: Centro de Biología Molecular Severo Ochoa (CSIC-UAM). Campus de la Universidad Autónoma de Madrid, Cantoblanco, Madrid 28049, Spain. Tel.: 34-91-397-8493; Fax: 34-91-397-4799. E-mail: lblanco@cbm.uam.es.

Published, JBC Papers in Press, January 30, 2002, DOI 10.1074/jbc.M111601200

    ABBREVIATIONS

The abbreviations used are: pol, DNA polymerase; BRCT, BRCA1 C terminus; BSA, bovine serum albumin; dd, dideoxy; dRP, 5'-deoxyribose 5-phosphate; DTT, dithiothreitol; EST, expressed sequence tag; HPRT, hypoxanthine guanine phosphoribosyl transferase; IPTG, isopropyl-beta -D-thiogalactopyranoside; Ni-NTA, nickel-nitrilotriacetic acid; PC, phosphocellulose.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Brautigam, C. A., and Steitz, T. A. (1998) Curr. Opin. Struct. Biol. 8, 54-63[CrossRef][Medline] [Order article via Infotrieve]
2. Steitz, T. A. (1999) J. Biol. Chem. 274, 17395-17398[Free Full Text]
3. Goodman, M. F., and Tippin, B. (2000) Nat. Rev. Mol. Cell. Biol. 1, 101-109[CrossRef][Medline] [Order article via Infotrieve]
4. Hübscher, U., Nasheuer, H. P., and Syväoja, J. E. (2000) Trends Biochem. Sci. 25, 143-147[CrossRef][Medline] [Order article via Infotrieve]
5. Friedberg, E. C., Feaver, W. J., and Gerlach, V. L. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 5681-5683[Free Full Text]
6. Livneh, Z. (2001) J. Biol. Chem. 276, 25639-25642[Free Full Text]
7. Hirose, F., Hotta, Y., Yamaguchi, M., and Matsukage, A. (1989) Exp. Cell Res. 181, 169-180[CrossRef][Medline] [Order article via Infotrieve]
8. Singhal, R. K., and Wilson, S. H. (1993) J. Biol. Chem. 268, 15906-15911[Abstract/Free Full Text]
9. Lindahl, T., and Wood, R. D. (1998) Science 286, 1897-1905
10. Krokan, H. E., Nilsen, H., Skorpen, F., Otterlei, M., and Slupphaug, G. (2000) FEBS Lett. 476, 73-77[CrossRef][Medline] [Order article via Infotrieve]
11. Beard, W. A., and Wilson, S. H. (2000) Mut. Res. 460, 231-244[Medline] [Order article via Infotrieve]
12. Ito, J., and Braithwaite, D. K. (1991) Nucleic Acids Res. 19, 4045-4057[Free Full Text]
13. Aravind, L., and Koonin, E. V. (1999) Nucleic Acids Res. 27, 1609-1618[Abstract/Free Full Text]
14. Benedict, C. L., Gilfillan, S., Thai, T. H., and Kearney, J. F. (2000) Immunol. Rev. 175, 150-157[CrossRef][Medline] [Order article via Infotrieve]
15. Prasad, R., Widen, S. G., Singhal, R. K., Watkins, J., Prakash, L., and Wilson, S. H. (1993) Nucleic Acids Res. 21, 5301-5307[Abstract/Free Full Text]
16. Shimizu, K., Santocanale, C., Ropp, P. A., Longhese, M. P., Plevani, P., Lucchini, G., and Sugino, A. (1993) J. Biol. Chem. 268, 27148-27153[Abstract/Free Full Text]